183 related articles for article (PubMed ID: 20850528)
21. A monoclonal antibody against CD86 and its protection in a murine lupus nephritis model of chronic graft-versus-host disease.
Han L; Shen L; Zhu Y; Qiu Y
Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):285-291. PubMed ID: 28747139
[TBL] [Abstract][Full Text] [Related]
22. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
[TBL] [Abstract][Full Text] [Related]
23. A truncated IL-12rβ1 receptor ameliorates chronic graft-versus-host disease-induced lupus nephritis by inhibiting Th1 and Th17 cells.
Wang C; Guo W; Cai D; Wang X; Yu D; Gao X; Yao W
Int Immunopharmacol; 2015 Dec; 29(2):544-551. PubMed ID: 26474696
[TBL] [Abstract][Full Text] [Related]
24. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
[TBL] [Abstract][Full Text] [Related]
25. Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice.
Steffens S; Burger F; Pelli G; Dean Y; Elson G; Kosco-Vilbois M; Chatenoud L; Mach F
Circulation; 2006 Oct; 114(18):1977-84. PubMed ID: 17043169
[TBL] [Abstract][Full Text] [Related]
26. Orally administered lactoperoxidase ameliorates dextran sulfate sodium-induced colitis in mice by up-regulating colonic interleukin-10 and maintaining peripheral regulatory T cells.
Shin K; Horigome A; Yamauchi K; Yaeshima T; Iwatsuki K
Int Immunopharmacol; 2009 Nov; 9(12):1387-93. PubMed ID: 19723594
[TBL] [Abstract][Full Text] [Related]
27. Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis.
Quezada SA; Eckert M; Adeyi OA; Schned AR; Noelle RJ; Burns CM
Arthritis Rheum; 2003 Sep; 48(9):2541-54. PubMed ID: 13130474
[TBL] [Abstract][Full Text] [Related]
28. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
29. Mangiferin Attenuates Murine Lupus Nephritis by Inducing CD4+Foxp3+ Regulatory T Cells via Suppression of mTOR Signaling.
Liang CL; Lu W; Zhou JY; Chen Y; Zhang Q; Liu H; Qiu F; Dai Z
Cell Physiol Biochem; 2018; 50(4):1560-1573. PubMed ID: 30359968
[TBL] [Abstract][Full Text] [Related]
30. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
32. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
[TBL] [Abstract][Full Text] [Related]
34. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
[TBL] [Abstract][Full Text] [Related]
35. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
36. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
Hahn BH; Anderson M; Le E; La Cava A
Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
[TBL] [Abstract][Full Text] [Related]
37. Contrasting in vivo effects on T helper cell functions induced by mitogenic (intact) versus nonmitogenic (F(ab')2) anti-CD3 monoclonal antibody.
Sawchuk SS; Gates R; Hirsch R
Transplantation; 1995 Dec; 60(11):1331-7. PubMed ID: 8525530
[TBL] [Abstract][Full Text] [Related]
38. Anti-IL-12/23 p40 antibody attenuates chronic graft-versus-host disease with lupus nephritis via inhibiting Tfh cell in mice.
Gao Y; Zeng Y; Xue W; Chen Y; Li Q; Bian Z; Tang L; Tang T; Chen C; Gao X; Guo W
Biomed Pharmacother; 2020 Sep; 129():110396. PubMed ID: 32580046
[TBL] [Abstract][Full Text] [Related]
39. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice.
Reilly CM; Thomas M; Gogal R; Olgun S; Santo A; Sodhi R; Samy ET; Peng SL; Gilkeson GS; Mishra N
J Autoimmun; 2008 Sep; 31(2):123-30. PubMed ID: 18650065
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]